About BIO-key International, Inc. - Common Stock (BKYI)
Bio-Key International, Inc. is a cybersecurity company that specializes in biometric identity verification solutions. The firm offers advanced technology for secure access and authentication, enabling organizations to manage user identities and streamline access to sensitive information while enhancing security protocols. Their products cater to various sectors, including healthcare, finance, and government, providing tools for both physical and logical access control. Bio-Key's innovative offerings are designed to meet the growing demand for reliable identity management and fraud prevention in an increasingly digital world. Read More
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
BIO-Key International shares are moving higher on Wednesday after the company announced that the National Bank of Egypt is deploying its PortalGuard Platform.
ATLANTIC CITY, NJ and HOLMDEL, NJ / ACCESSWIRE / January 10, 2025 / BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless, and phish-resistant authentication, will present and meet with investors at DealFlow Event's Microcap Conference on Wednesday, January 29th & 30th at the Borgata hotel in Atlantic City, New Jersey.
As market momentum builds, five stocks across diverse sectors are showing signs of significant movement, approaching crucial technical trendlines that could set the stage for breakout performances. These companies have captured investor attention as they align near important resistance levels. Each company brings sector-specific innovation, from tech advancements in mmWave and biometric authentication to cutting-edge oncology therapies, positioning them to potentially drive gains as they test these key thresholds.
